The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas

European Journal of Internal Medicine

Volumn 22, Issue 6, 2011, Pages

  Karaman, Kerem ^a   Bostanci, Erdal Birol ^a   Aksoy, Erol ^a   Kurt, Mevlut ^b   Celep, Bahadir ^a   Ulas, Murat ^a   Dalgic, Tahsin ^a   Surmelioglu, Ali ^a   Hayran, Mutlu ^c   Akoglu, Musa ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Turkiye Yuksek Ihtisas Teaching and Research Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

CA19 9; Mean platelet volume; Neuroendocrine tumor; Pancreas adenocarcinoma

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GASTRINOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULINOMA; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE VOLUME;

ADENOCARCINOMA; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CA-19-9 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATOLOGIC TESTS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80855143655     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.04.005     Document Type: Article

References (23)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. G. Benassai, M. Mastrorilli, G. Quarto, A. Cappiello, U. Giani, and P. Forestieri Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas J Surg Oncol 73 2000 212 218 (Pubitemid 30238413)
3. L. Grenacher, and M. Klauss Computed tomography of pancreatic tumors Radiologe 49 2009 107 123
4. Y.M. Ku, S.S. Shin, C.H. Lee, and R.C. Semelka Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms Top Magn Reson Imaging 20 2009 11 18
5. A. Khalid Differentiating neoplastic from benign lesions of the pancreas: translational techniques Clin Gastroenterol Hepatol 7 2009 55 58
6. J. Iglesias García, J. Lariño Noia, and J.E. Domínguez Muñoz Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer Rev Esp Enferm Dig 10 2009 631 638
7. F. Pakzad, A.M. Groves, and P.J. Ell The role of positron emission tomography in the management of pancreatic cancer Semin Nucl Med 36 2006 248 256 (Pubitemid 43817848)
8. H.L. O'Grady, and K.C. Conlon Pancreatic neuroendocrine tumours Eur J Surg Oncol 3 2008 324 332 (Pubitemid 351312867)
9. H. Chen, J.M. Hardacre, A. Uzar, J.L. Cameron, and M.A. Choti Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 1998 88 92
10. L.C. Fry, K. Mönkemüller, and P. Malfertheiner Molecular markers of pancreatic cancer: development and clinical relevance Langenbecks Arch Surg 393 2008 883 890
11. S. Boeck, P. Stieber, S. Holdenrieder, R. Wilkowski, and V. Heinemann Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer Oncology 70 2006 255 264 (Pubitemid 44670165)
12. K.S. Goonetilleke, and A.K. Siriwardena Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer Eur J Surg Oncol 33 2007 266 270 (Pubitemid 46488663)
13. M.J. Duffy, C. Sturgeon, R. Lamerz, C. Haglund, V.L. Holubec, and R. Klapdor Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report Ann Oncol 21 2010 441 447
14. A.Y. Gasparyan, L. Ayvazyan, D.P. Mikhailidis, and G.D. Kitas Mean platelet volume: a link between thrombosis and Inflammation? Curr Pharm Des 17 2011 47 58
15. C. Briggs Quality counts: new parameters in blood cell counting Int J Lab Hematol 31 2009 277 297
16. J. Osada, M. Rusak, Z. Kamocki, M.I. Dabrowska, and B. Kedra Platelet activation in patients with advanced gastric cancer Neoplasma 57 2010 145 150
17. S. Aksoy, S. Kilickap, M. Hayran, H. Harputluoglu, E. Koca, and D.S. Dede Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors Int J Lab Hematol 30 2008 214 219 (Pubitemid 351679514)
18. S. Baatout Interleukin-6 and megakaryocytopoiesis: an update Ann Hematol 73 1996 157 162 (Pubitemid 26381693)
19. F.G. Berger The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality Breast Cancer Res Treat 88 2004 281 285 (Pubitemid 40137307)
20. M. Trikha, R. Corringham, B. Klein, and J.F. Rossi Targeted antiinterleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence Clin Cancer Res 9 2003 4653 4665 (Pubitemid 37323267)
21. R. Talar-Wojnarowska, A. Gasiorowska, B. Smolarz, H. Romanowicz-Makowska, A. Kulig, and E. Malecka-Panas Clinical significance of interleukin-6 (IL-6) gene polymorphism and IL-6 serum level in pancreatic adenocarcinoma and chronic pancreatitis Dig Dis Sci 54 2009 683 689
22. M.C. Berković, M. Jokić, J. Marout, S. Radosević, V. Zjacić-Rotkvić, and S. Kapitanović IL-6-174C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Exp Mol Pathol 83 2007 474 479 (Pubitemid 350087037)
23. I. Ertenli, S. Kiraz, M.A. Oztürk, I. Haznedaroǧlu, I. Celik, and M. Calgüneri Pathologic thrombopoiesis of rheumatoid arthritis Rheumatol Int 23 2003 49 60 (Pubitemid 36384721)